# Expert publications
**Source**: https://about.uq.edu.au/experts-publication/1526/4751
**Parent**: https://about.uq.edu.au/experts/1526
[All
(879)](https://about.uq.edu.au/experts-publication/1526/all)
[Book
(2)](https://about.uq.edu.au/experts-publication/1526/4747)
[Journal Article
(794)](https://about.uq.edu.au/experts-publication/1526/4748)
[Other Outputs
(2)](https://about.uq.edu.au/experts-publication/1526/4749)
[Conference Publication
(54)](https://about.uq.edu.au/experts-publication/1526/4751)
[Book Chapter
(27)](https://about.uq.edu.au/experts-publication/1526/4752)
| |
| --- |
| 2025 Conference Publication Initial Results of the Apaxan Trial: a prospective, open-label, randomized controlled trial on pharmacokinetics of highly protein bound direct oral anticoagulant (apixaban) in prevention and treatment of primary nephrotic syndrome associated thromboembolic disease Chandler, Shaun, Wallis, Steven, Taylor, Tanu, Tseng, Shih- Han, Wang, Jue, Han, Thin, Ng, Monica, Roberts, Jason, Thet, Zaw and Ranganathan, Dwarakanathan (2025). Initial Results of the Apaxan Trial: a prospective, open-label, randomized controlled trial on pharmacokinetics of highly protein bound direct oral anticoagulant (apixaban) in prevention and treatment of primary nephrotic syndrome associated thromboembolic disease. 60th ANZSN Congress, Perth, WA, Australia, 30 August - 3 September 2025. Hoboken, NJ, United States: Wiley. doi: 10.1111/nep.70088 [Initial Results of the Apaxan Trial: a prospective, open-label, randomized controlled trial on pharmacokinetics of highly protein bound direct oral anticoagulant (apixaban) in prevention and treatment of primary nephrotic syndrome associated thromboembolic disease](https://espace.library.uq.edu.au/view/UQ:0d64e26) |
| 2025 Conference Publication Is fluconazole or voriconazole lost during a paediatric renal replacement therapy simulation? An ex-vivo study Cree, Michele, Schlapbach, Luregn, Wallis, Steve and Roberts, Jason (2025). Is fluconazole or voriconazole lost during a paediatric renal replacement therapy simulation? An ex-vivo study. Australian and New Zealand Intensive Care Society/Australian College of Critical Care Nursing Intensive Care Annual Scientific meeting 2025, Christchurch, New Zealand, 9-11 April 2025. Philadelphia, PA United States: Elsevier. doi: 10.1016/j.aucc.2025.101329 [Is fluconazole or voriconazole lost during a paediatric renal replacement therapy simulation? An ex-vivo study](https://espace.library.uq.edu.au/view/UQ:afe1172) |
| 2025 Conference Publication Fluconazole and voriconazole loss during extracorporeal membrane oxygenation (ECMO) – an ex-vivo study in an infant Cree, Michele, Haisz, Emma, Sumi, Chandra, Wallis, Steve, Schlapbach, Luregn J. and Roberts, Jason (2025). Fluconazole and voriconazole loss during extracorporeal membrane oxygenation (ECMO) – an ex-vivo study in an infant. Australian and New Zealand Intensive Care Society/Australian College of Critical Care Nursing Intensive Care Annual Scientific meeting 2025, Christchurch, New Zealand, 9-11 April 2025. Philadelphia, PA United States: Elsevier. doi: 10.1016/j.aucc.2025.101328 [Fluconazole and voriconazole loss during extracorporeal membrane oxygenation (ECMO) – an ex-vivo study in an infant](https://espace.library.uq.edu.au/view/UQ:b33ac8a) |
| 2025 Conference Publication Defining Optimal Sampling Times for Cefepime Therapeutic Drug Monitoring in Clinical Practice Rhodes, Nathaniel J., Smith, Brandon, Shields, Ryan K., Pan, Samantha, Weslander, Erin, Galvin, Shannon, Hughes, Jasmine, Hughes, Maria-Stephanie, Sime, Fekade B., Roberts, Jason A., Kiel, Patrick J., Neely, Michael N. and Scheetz, Marc H. (2025). Defining Optimal Sampling Times for Cefepime Therapeutic Drug Monitoring in Clinical Practice. IDWeek 2024, Los Angeles, CA United States, 16-19 October 2024. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ofid/ofae631.069 [Defining Optimal Sampling Times for Cefepime Therapeutic Drug Monitoring in Clinical Practice](https://espace.library.uq.edu.au/view/UQ:33622ae) |
| 2024 Conference Publication Does renal replacement therapy (RRT) circuitry remove common antibiotics? An ex-vivo study simulating pediatric treatment Cree, Michele, Wallis, S., Schlapbach, L., Roberts, J. and Parker, S. (2024). Does renal replacement therapy (RRT) circuitry remove common antibiotics? An ex-vivo study simulating pediatric treatment. 12th World Congress on Pediatric Intensive and Critical Care, Cancun, Mexico, 1-5 June 2024. Philadelphia, PA United States: Lippincott Williams & Wilkins. doi: 10.1097/01.pcc.0001085192.44125.4e [Does renal replacement therapy (RRT) circuitry remove common antibiotics? An ex-vivo study simulating pediatric treatment](https://espace.library.uq.edu.au/view/UQ:c9c4d7e) |
| 2024 Conference Publication Sequestration of common antibiotics onto a pediatric extracorporeal membrane oxygenation (ECMO) circuit? An ex-vivo study Cree, Michele, Haisz, E., Wallis, S., Schlapbach, L., Roberts, J. and Parker, S. (2024). Sequestration of common antibiotics onto a pediatric extracorporeal membrane oxygenation (ECMO) circuit? An ex-vivo study. 12th World Congress on Pediatric Intensive and Critical Care, Cancun, Mexico, 1-5 June 2024. Philadelphia, PA United States: Lippincott Williams & Wilkins. doi: 10.1097/01.pcc.0001085588.32445.76 [Sequestration of common antibiotics onto a pediatric extracorporeal membrane oxygenation (ECMO) circuit? An ex-vivo study](https://espace.library.uq.edu.au/view/UQ:d07e856) |
| 2024 Conference Publication The national inpatient penicillin allergy database: A framework for health services penicillin allergy research Mitri, Elise, James, Fiona, Fletcher, Luke, Turner, Maureen, Ierano, Courtney, Roberts, Jason, Fernando, Suran, De Luca, Joseph and Trubiano, Jason (2024). The national inpatient penicillin allergy database: A framework for health services penicillin allergy research. Annual Meeting of the American Academy of Allergy Asthma and Immunology (AAAAI), Washington, DC United States, 23-26 February 2024. Philadelphia, PA United States: Elsevier. [The national inpatient penicillin allergy database: A framework for health services penicillin allergy research](https://espace.library.uq.edu.au/view/UQ:4fdc4e8) |
| 2024 Conference Publication The fusion study – Compatibility of antibiotics with commonly used medication infusions in a paediatric intensive care unit Tu, Quyen, Won, Hayoung Helen, Sime, Fekade, Wallis, Steven, Raman, Sainath, Stacey, Sonya, Cotta, Menino, Schlapbach, Luregn and Roberts, Jason (2024). The fusion study – Compatibility of antibiotics with commonly used medication infusions in a paediatric intensive care unit. Australian and New Zealand Intensive Care Society/Australian College of Critical Care Nursing Intensive Care Annual Scientific meeting, Brisbane, QLD Australia, 10-12 April 2024. Philadelphia, PA United States: Elsevier. doi: 10.1016/j.aucc.2024.07.037 [The fusion study – Compatibility of antibiotics with commonly used medication infusions in a paediatric intensive care unit](https://espace.library.uq.edu.au/view/UQ:d9d80fe) |
| 2023 Conference Publication Optimizing Immunoglobulin Replacement Therapy for Patients with B-Cell Malignancies and Hypogammaglobulinemia: The Investigator-Initiated, International, Randomized Phase II/III Rational Platform Trial, and the Rationalise (STOP IgRT) Domain Wood, Erica M., Chai, Khai Li, Reynolds, John, Griffiths, Jennifer, Beaton, Brendan, Callum, Jeannie, Crassini, Kyle R., Crispin, Philip J., Fanning, Laura, Gilbertson, Michael, Grigg, Andrew P., Hawkes, Eliza A., Morrissey, C. Orla, Mulligan, Stephen P., Opat, Stephen S., Paterson, David L., Petrie, Dennis, Roberts, Jason A., Ryan, Elizabeth G., Spencer, Andrew, Stanworth, Simon J., Thao, Le Thi Phuong, Trotman, Judith, Waters, Neil A., Weinkove, Robert and McQuilten, Zoe K. (2023). Optimizing Immunoglobulin Replacement Therapy for Patients with B-Cell Malignancies and Hypogammaglobulinemia: The Investigator-Initiated, International, Randomized Phase II/III Rational Platform Trial, and the Rationalise (STOP IgRT) Domain. 65th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA United States, 9-12 December 2023. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2023-181541 [Optimizing Immunoglobulin Replacement Therapy for Patients with B-Cell Malignancies and Hypogammaglobulinemia: The Investigator-Initiated, International, Randomized Phase II/III Rational Platform Trial, and the Rationalise (STOP IgRT) Domain](https://espace.library.uq.edu.au/view/UQ:c87add0) |
| 2023 Conference Publication Trimethoprim-sulfamethoxazole pharmacokinetic evaluation in adult kidney transplant recipients. Scuderi, C.E., Parker, S.L., Jacks, M., John, G.T., McWhinney, B., Ungerer, J., Mallett, A.J., Healy, H.G., Roberts, J.A. and Staatz, C.E. (2023). Trimethoprim-sulfamethoxazole pharmacokinetic evaluation in adult kidney transplant recipients.. World Congress on Pharmacy and Pharmaceutical Sciences., Brisbane, QLD Australia, 24-28 September 2023. [Trimethoprim-sulfamethoxazole pharmacokinetic evaluation in adult kidney transplant recipients.](https://espace.library.uq.edu.au/view/UQ:2f3d44a) |
| 2023 Conference Publication In vitro susceptibility testing of imipenem- relebactam and tedizolid against australian mycobacterium abscessus isolates Burke, A. J., Carter, R., Tolson, C., Congdon, J., Duplancic, C., Bursle, E., Bell, S., Roberts, J. and Thomson, R. (2023). In vitro susceptibility testing of imipenem- relebactam and tedizolid against australian mycobacterium abscessus isolates. ATS 2023 International Conference, Washington, DC USA, 19-24 May 2023. Washington, DC USA: American Thoracic Society. doi: 10.1164/ajrccm-conference.2023.207.1\_meetingabstracts.a2968 [In vitro susceptibility testing of imipenem- relebactam and tedizolid against australian mycobacterium abscessus isolates](https://espace.library.uq.edu.au/view/UQ:7e6c413) |
| 2023 Conference Publication Does renal replacement therapy impact the clearance of meropenem, piperacillin, tazobactam and vancomycin in a critically ill child? An ex vivo study Cree, Michele, Schlapbach, Luregn, Sumi, Chandra, Wallis, Steve, Roberts, Jason and Parker, Suzanne (2023). Does renal replacement therapy impact the clearance of meropenem, piperacillin, tazobactam and vancomycin in a critically ill child? An ex vivo study. ANZICS/ACCCN Intensive Care Annual Scientific Meeting, Adelaide, SA Australia, 29-31 March 2023. Philadelphia, PA United States: Elsevier. doi: 10.1016/j.aucc.2023.07.020 [Does renal replacement therapy impact the clearance of meropenem, piperacillin, tazobactam and vancomycin in a critically ill child? An ex vivo study](https://espace.library.uq.edu.au/view/UQ:48082d0) |
| 2023 Conference Publication Are meropenem, piperacillin, tazobactam and vancomycin sequestered onto a paediatric extracorporeal membrane oxygenation circuit? An ex vivo study Cree, Michele, Haisz, Emma, Sumi, Chandra, Wallis, Steve, Schlapbach, Luregn, Roberts, Jason and Parker, Suzanne (2023). Are meropenem, piperacillin, tazobactam and vancomycin sequestered onto a paediatric extracorporeal membrane oxygenation circuit? An ex vivo study. ANZICS/ACCCN Intensive Care Annual Scientific Meeting, Adelaide, SA Australia, 29-31 March 2023. Philadelphia, PA United States: Elsevier. doi: 10.1016/j.aucc.2023.07.023 [Are meropenem, piperacillin, tazobactam and vancomycin sequestered onto a paediatric extracorporeal membrane oxygenation circuit? An ex vivo study](https://espace.library.uq.edu.au/view/UQ:2ddcee5) |
| 2022 Conference Publication Pharmacokinetics of polymyxin B and the pharmacokinetic/pharmacodynamic target attainment in hospitalised adult patients with multidrug-resistant gram-negative infections Zamri, Puteri Juanita, Abdul-Aziz, Mohd-Hafiz, Hernandez-Mitre, Maria Patricia, Hasan, Mohd Shahnaz, Shariff, Izyani Md, Sulaiman, Helmi, Wallis, Steve, Sumi, Chandra Datta, Sime, Fekade Bruck and Roberts, Jason A (2022). Pharmacokinetics of polymyxin B and the pharmacokinetic/pharmacodynamic target attainment in hospitalised adult patients with multidrug-resistant gram-negative infections. 32nd International Congress of Antimicrobial Chemotherapy (ICC), Perth, Australia, 27-30 November 2022. Amsterdam, Netherlands: Elsevier . doi: 10.1016/s2213-7165(22)00339-3 [Pharmacokinetics of polymyxin B and the pharmacokinetic/pharmacodynamic target attainment in hospitalised adult patients with multidrug-resistant gram-negative infections](https://espace.library.uq.edu.au/view/UQ:bc838fc) |
| 2022 Conference Publication Demographic, clinical and molecular epidemiology of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli bloodstream infections in Central Australia Langham, Freya, Tsai, Danny, Camilleri, Shayne, Forde, Brian, Harris, Patrick, Roberts, Jason A. and Chiong, Fabian (2022). Demographic, clinical and molecular epidemiology of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli bloodstream infections in Central Australia. 32nd International Congress of Antimicrobial Chemotherapy (ICC), Perth, WA Australia, 27-30 November 2022. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s2213-7165(22)00286-7 [Demographic, clinical and molecular epidemiology of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli bloodstream infections in Central Australia](https://espace.library.uq.edu.au/view/UQ:2bd8bd0) |
| 2022 Conference Publication Tacrolimus, mycophenolate and prednisolone concentration monitoring using microsampling instead of venepuncture in kidney transplant patients Scuderi, C. E., Parker, S. L., Jacks, M., John, G. T., McWhinney, B., Ungerer, J., Mallett, A. J., Healy, H. G., Roberts, J. A. and Staatz, C. E. (2022). Tacrolimus, mycophenolate and prednisolone concentration monitoring using microsampling instead of venepuncture in kidney transplant patients. Society of Hospital Pharmacists of Australia, Brisbane, QLD, Australia, 1-3 December 2022. [Tacrolimus, mycophenolate and prednisolone concentration monitoring using microsampling instead of venepuncture in kidney transplant patients](https://espace.library.uq.edu.au/view/UQ:77ef2fc) |
| 2022 Conference Publication Evaluating mono- and combination therapy of meropenem and amikacin against Pseudomonas aeruginosa bacteremia in the hollow-fiber infection model Avent, Minyon, Mccarthy, Kate, Sime, Fekade, Naickera, Saiyuri, Heffernan, Aaron, Wallis, Steven, Paterson, David and Roberts, Jason A (2022). Evaluating mono- and combination therapy of meropenem and amikacin against Pseudomonas aeruginosa bacteremia in the hollow-fiber infection model. 32nd International Congress of Antimicrobial Chemotherapy (ICC), Perth, WA, Australia, 27-30 November 2022. Amsterdam, Netherlands: Elsevier . doi: 10.1016/s2213-7165(22)00314-9 [Evaluating mono- and combination therapy of meropenem and amikacin against Pseudomonas aeruginosa bacteremia in the hollow-fiber infection model](https://espace.library.uq.edu.au/view/UQ:04ee2cb) |
| 2022 Conference Publication Anticoagulation and antiplatelet strategies in non-critically ill patients with Covid-19 McQuilten, Zoe, Venkatesh, Balasubramanian, Jha, Vivekanand, Roberts, Jason, Morpeth, Susan, Totterdell, James, McPhee, Grace, Abraham, John, Bam, Niraj, Bandara, Methma, Bangi, Ashpak, Barina, Lauren, Basnet, Bhupendra, Bhally, Hasan, Bhusal, Khemr, Bogati, Umesh, Bowen, Asha, Burke, Andrew, Christopher, Devasahayam, Chunilal, Sanjeev, Cochrane, Belinda, Curnow, Jennifer, Reddy, Varaprasad Babu Dara, Das, Santa, Dhungana, Ashesh, Di Tanna, Gian Luca, Dotel, Ravindra, DSouza, Hyjel, Dummer, Jack ... Tong, Steven Y. C. (2022). Anticoagulation and antiplatelet strategies in non-critically ill patients with Covid-19. 64th Annual Meeting and Exposition of the American Society of Hematology (ASH), New Orleans, LA United States, 10-13 December 2022. Amsterdam, Netherlands: Elsevier. doi: 10.1182/blood-2022-168448 [Anticoagulation and antiplatelet strategies in non-critically ill patients with Covid-19](https://espace.library.uq.edu.au/view/UQ:3df03d2) |
| 2022 Conference Publication Is creatine and tacrolimus measurement through VAMS microsampling the future for adult kidney transplant patients? Scuderi, C., Parker, S., John, G., McWhinney, B., Ungerer, J., Mallett, A., Roberts, J., Healy, H. and Staatz, C. E. (2022). Is creatine and tacrolimus measurement through VAMS microsampling the future for adult kidney transplant patients?. Australian and New Zealand Society of Nephrology meeting, Sydney, NSW Australia, October 2022. [Is creatine and tacrolimus measurement through VAMS microsampling the future for adult kidney transplant patients?](https://espace.library.uq.edu.au/view/UQ:0378185) |
| 2022 Conference Publication Can microsampling methods replace venepuncture for simultaneous therapeutic drug monitoring of tacrolimus, mycophenolic acid and prednisolone concentrations in adult kidney transplant patients? Scuderi, Carla, Parker, Suzanne, Jacks, Margaret, John, George, McWhinney, Brett, Ungerer, Jacobus, Mallett, Andrew, Healy, Helen, Roberts, Jason and Staatz, Christine (2022). Can microsampling methods replace venepuncture for simultaneous therapeutic drug monitoring of tacrolimus, mycophenolic acid and prednisolone concentrations in adult kidney transplant patients?. 57th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology (ANZSN), Sydney, NSW Australia, 17-19 October 2022. Richmond, VIC Australia: John Wiley & Sons. [Can microsampling methods replace venepuncture for simultaneous therapeutic drug monitoring of tacrolimus, mycophenolic acid and prednisolone concentrations in adult kidney transplant patients?](https://espace.library.uq.edu.au/view/UQ:9bb38a2) |